114 related articles for article (PubMed ID: 2112207)
1. [Clinical evaluation of therapy for aspiration pneumonia with imipenem/cilastatin sodium].
Kikuchi N; Onozaki I; Kohno N; Yamaguchi T; Nagao K; Kuriyama T; Kanno H; Kubo S; Tatsumi K; Okita S
Jpn J Antibiot; 1990 Jan; 43(1):23-30. PubMed ID: 2112207
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of imipenem/cilastatin sodium in the treatment of respiratory tract infections].
Shimokata K; Kawazu H; Nishiwaki K; Yamamoto M; Sakai S; Senda Y; Torii Y; Amano H; Saka H; Saito H
Jpn J Antibiot; 1990 Jan; 43(1):14-22. PubMed ID: 2348550
[TBL] [Abstract][Full Text] [Related]
3. Tazobactam/piperacillin for moderate-to-severe pneumonia in patients with risk for aspiration: comparison with imipenem/cilastatin.
Ito I; Kadowaki S; Tanabe N; Haruna A; Kase M; Yasutomo Y; Tsukino M; Nakai A; Matsumoto H; Niimi A; Chin K; Ichiyama S; Mishima M
Pulm Pharmacol Ther; 2010 Oct; 23(5):403-10. PubMed ID: 20561917
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetic, bacteriological and clinical studies on imipenem/cilastatin sodium in neonates].
Hashira S; Tajima T; Fujii R
Jpn J Antibiot; 1989 May; 42(5):1077-86. PubMed ID: 2746857
[TBL] [Abstract][Full Text] [Related]
5. [Clinical efficacy of imipenem/cilastatin sodium in patients with respiratory tract infections caused by Pseudomonas aeruginosa].
Mikasa K; Sawaki M; Konishi M; Narita N
Jpn J Antibiot; 1990 Jan; 43(1):9-13. PubMed ID: 2112208
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacokinetic, bacteriological and clinical studies on imipenem/cilastatin sodium in neonates].
Iwai N; Nakamura H; Miyazu M; Kasai K; Taneda Y
Jpn J Antibiot; 1989 May; 42(5):1087-101. PubMed ID: 2746858
[TBL] [Abstract][Full Text] [Related]
7. Imipenem/cilastatin as secondary therapy for bacterial infections.
Kono K; Onuki K; Tohara S; Takeda S
Clin Ther; 1991; 13(4):448-56. PubMed ID: 1933995
[TBL] [Abstract][Full Text] [Related]
8. [Imipenem/cilastatin sodium alone or combined with amikacin sulfate in respiratory infections].
Takamoto M; Ishibashi T; Toyoshima H; Tanaka H; Tamaru N; Watanabe K; Yoshida M; Tokunaga N; Ichikawa Y; Oizumi K
Jpn J Antibiot; 1994 Sep; 47(9):1131-44. PubMed ID: 7990255
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of imipenem/cilastatin sodium in the internal medicine].
Fukuhara H; Kusano N; Nakamura H; Kaneshima H; Irabu Y; Shimozi K; Kitukawa K; Shigeno Y; Saito A; Kakazu T
Jpn J Antibiot; 1991 Aug; 44(8):877-85. PubMed ID: 1920813
[TBL] [Abstract][Full Text] [Related]
10. [Chemotherapy with imipenem/cilastatin for severe infections accompanied by malignant hematological disorders].
Fujii Y; Inoue Y; Hiroshige Y; Kaku K; Kaneko T
Jpn J Antibiot; 1993 Mar; 46(3):259-68. PubMed ID: 8510323
[TBL] [Abstract][Full Text] [Related]
11. [Clinical evaluation of imipenem/cilastatin sodium as a second line regimen in severe infections associated with hematologic disorders].
Tsuda S; Nakai H; Murakami T; Seryu S; Takashima T; Tanaka S; Nakagawa H; Nishigaki H; Okuda T; Nishida K
Jpn J Antibiot; 1991 Aug; 44(8):886-98. PubMed ID: 1920814
[TBL] [Abstract][Full Text] [Related]
12. [Domestic imipenem cilastatin sodium for the treatment of severe aspiration pneumonia, a curative effect observation].
Yin HY; Ye XL; Zhang R; Zhu YF
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Oct; 24(10):628-31. PubMed ID: 23040783
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacokinetic and clinical evaluations of imipenem/cilastatin sodium in neonates and premature infants].
Motohiro T; Sakata Y; Oda K; Kawakami A; Tanaka K; Koga T; Shimada Y; Tomita S; Fujimoto T; Tominaga K
Jpn J Antibiot; 1989 May; 42(5):1102-24. PubMed ID: 2664254
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests.
Jean SS; Hsieh TC; Hsu CW; Lee WS; Bai KJ; Lam C
J Microbiol Immunol Infect; 2016 Dec; 49(6):924-933. PubMed ID: 26341302
[TBL] [Abstract][Full Text] [Related]
15. [Imipenem/cilastatin sodium and other beta-lactams for respiratory tract infections: clinical benefit and treatment days for cure].
Oizumi K; Rikimaru T; Shiraishi T; Motohiro A; Yoshida M; Watanabe K; Maruyama R; Ishibashi T; Kitahara Y; Kido M; Yoshii C; Hara N; Ikeda A; Yamada H; Ninomiya K; Matsuzaki Y; Ichinose Y; Namba K; Kodama T; Kunitake R; Miyazaki N; Abe K; Matsunaga R; Ide H; Kamae I
Jpn J Antibiot; 1999 Jan; 52(1):1-15. PubMed ID: 10202683
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetic and clinical studies on imipenem/cilastatin sodium in the perinatal period. A study of imipenem/cilastatin sodium in the perinatal co-research group].
Matsuda S; Suzuki M; Oh K; Ishikawa M; Soma A; Takada H; Shimizu T; Makinoda S; Fujimoto S; Chimura T
Jpn J Antibiot; 1988 Nov; 41(11):1731-41. PubMed ID: 3062205
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic efficacy of imipenem/cilastatin sodium on respiratory tract infections in lung cancer patients].
Yamamoto M; Ina Y; Takada K; Noda M; Morishita M; Senda Y; Torii Y; Kakihara H; Yoshikawa K; Sugiura T
Jpn J Antibiot; 1991 Apr; 44(4):388-97. PubMed ID: 1652653
[TBL] [Abstract][Full Text] [Related]
18. [Clinical effect of the combined therapy of arbekacin and imipenem/cilastatin against methicillin-resistant Staphylococcus aureus].
Hashimoto A; Ohtsubo T; Tomono K; Kaku M; Koga H; Kohno S; Hara K; Sugiyama H; Taira K; Inoue Y
Jpn J Antibiot; 1994 Jun; 47(6):804-12. PubMed ID: 8072190
[TBL] [Abstract][Full Text] [Related]
19. [In vitro interaction of piperacillin and imipenem/cilastatin combined with aminoglycosides against Pseudomonas aeruginosa].
Yamashiro Y; Ogake N; Takahata M; Minami S
Jpn J Antibiot; 2000 Apr; 53(4):194-200. PubMed ID: 10868299
[TBL] [Abstract][Full Text] [Related]
20. The antimicrobial activity of imipenem/cilastatin and its treatment in critical ill patients with polymicrobial and mixed infection.
Leu HS; Wu JL
Changgeng Yi Xue Za Zhi; 1993 Sep; 16(3):154-63. PubMed ID: 8221288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
